Skip to main content
. 2023 Sep 29;72(39):1065–1071. doi: 10.15585/mmwr.mm7239a4

FIGURE.

The figure is a two-panel stacked histogram indicating the percentage of pregnant women in the United States who were hesitant about receiving influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during 2019–20 through 2022–23 according to Internet panel survey data.

Percentage of pregnant women* who were hesitant† about receiving influenza vaccine (A) and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (B) — Internet panel survey, United States, 2019–20 through 2022–23 influenza seasons

Abbreviation: Tdap = tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis.

* Respondents who were pregnant at any time since August 1 and answered the hesitancy questions (2019–20: 2,261 [influenza and Tdap vaccines]; 2020–21: 2,287 [influenza vaccine] and 2,286 [Tdap vaccine]; 2021–22: 2,485 [influenza vaccine] and 2,484 [Tdap vaccine]; 2022–23: 2,327 [influenza vaccine] and 2,328 [Tdap vaccine]).

† Respondents were asked the following questions, “Overall, how hesitant are you about flu vaccination during your pregnancy?” and “Overall, how hesitant are you about Tdap vaccination during your pregnancy?“ Answer choices were 1) Not at all hesitant, 2) Not that hesitant, 3) Somewhat hesitant, and 4) Very hesitant.